Patient death spurs trial halt for Magenta Therapeutics
Magenta Therapeutics is pausing an early-stage clinical trial after a patient died. The death was deemed to be possibly related to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
